Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?

Antimicrob Agents Chemother. 2005 Nov;49(11):4816; author reply 4816-7. doi: 10.1128/AAC.49.11.4816-4817.2005.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acetamides / therapeutic use*
  • Humans
  • Linezolid
  • Methicillin Resistance
  • Oxazolidinones / therapeutic use*
  • Skin Diseases, Bacterial / drug therapy*
  • Soft Tissue Infections / drug therapy*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / drug effects*
  • Vancomycin / therapeutic use*

Substances

  • Acetamides
  • Oxazolidinones
  • Vancomycin
  • Linezolid